Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,710.00
-160.00 (-2.73%)
At close: Dec 5, 2025

Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 548.37 billion as of December 5, 2025. Its market cap has decreased by -17.59% in one year.

Market Cap
548.37B
Enterprise Value
519.01B
Revenue
1.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,710.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 548.37B, an increase of 1,054.60%. That is a compound annual growth rate of 11.34%.

History

DateMarket Cap% Change
Dec 5, 2025548.37B-2.40%
Dec 30, 2024561.85B-45.92%
Dec 28, 20231,038.98B-4.44%
Dec 29, 20221,087.24B11.39%
Dec 30, 2021976.10B-6.92%
Dec 30, 20201,048.68B115.45%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 75.96T
Celltrion 40.11T
ALTEOGEN 24.41T
ABL Bio 10.51T
SK Biopharmaceuticals 10.49T
Yuhan 8,755.13B
LigaChem Biosciences 6,753.15B
Peptron 6,645.44B
Market Cap Rankings